WebTORNTPHARM Income Statement 2024 Annual Report As per the latest Income Statement of TORNTPHARM, the Net revenue increased by ₹655.20M (1%)compared to the previous period. The operating income in 2024 increased by ₹3.0952B (20%). The net income as per the annual report was 12.52B which increased by ₹2.2716B (22%) compared to previous … WebPrice target 1723.52 0.00 0.00% The 31 analysts offering 1 year price forecasts for TORNTPHARM have a max estimate of — and a min estimate of —. Analyst rating …
LIVE Torrent Pharmaceuticals Ltd: Share Price NSE - Motilal Oswal
Web6 apr. 2024 · Torrent Pharmaceuticals Ltd. BSE: 500420, NSE: TORNTPHARM 1 Day -0.21% Market Capitalisation ₹53,280 Cr 12 Month Earnings ₹831 Cr Price to Earnings 63.90 Overview Key Ratios Peer Comparison Financials Share Holdings News Other details NSE ₹1,574.75 As on 06-Apr-2024 IST ₹-3.35 • -0.21 % Prev Close ₹ 1,578.10 Day's Open ₹ … WebNSETORNTPHARM1! At close See on super-charts Overview News Ideas TORNTPHARM1! chart 1 month Year to date Key stats Volume — Current contract … how to sync dropbox to computer
Latest Shareholding Pattern - Torrent Pharmaceuticals Ltd.
Web1 dag geleden · TORNTPHARM 1 m 3 m 5 m 15 m 30 m 1 h D Save *Delayed by 20 seconds. MC Insights Strong Performer Stock with good financial performance alongside … Get all latest & breaking news on Results. Watch videos, top stories and articles on … Get Comprehensive Weekly Technical Analysis of Torrent Pharmaceuticals Ltd. … Get daily stock, price updates, breaking news, views and real-time alerts on … Disclaimer : The views expressed in the forum are the views of the user writing … Yes Bank Share Price: Find the latest news on Yes Bank Stock Price. Get all the … Get Comprehensive Daily Technical Analysis of Torrent Pharmaceuticals Ltd. … WebTorrent Pharmaceuticals Ltd. engages in the research, development, manufacture, and marketing of generic pharmaceutical formulations. It offers pharmaceutical products to … Web21 mrt. 2024 · NSE-Medical-Generic Drugs Torrent Pharmac is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 6742.32 Cr. and Equity Capital is Rs. 84.62 Cr. for the Year ended 31/03/2024. readline for windows